The hope is the therapy can effectively target cancerous cells at relatively small doses while minimizing side effects.

The treatment of prostate cancer in Uganda follows similar principles to those used worldwide, including surgery, radiation ...

Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

Medically reviewed by Matthew Wosnitzer, MD Metastatic castration-resistant prostate cancer (mCRPC) is an advanced form of ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

This type of prostate cancer can be very hard to treat ... to talk to each other about your treatment options before you start a new therapy, so they can determine exactly how your cancer is ...

The phase 2a LEGION-100 trial seeks to evaluate the safety and effectiveness of the SYNC-T/SV-102 combination therapy for treating metastatic castration-resistant prostate cancer (mCRPC) and to ...

Cleveland Clinic Abu Dhabi, part of the M42 group, has achieved a historic milestone in global healthcare. In collaboration ...

Abu Dhabi is bringing the future of cancer care to the region with a world-class ‘heavy ion therapy’ facility in the UAE. It ...

Bayer will present new data from the ARANOTE trial evaluating ultra-low prostate-specific antigen responses with NUBEQA ® ...

Guidelines created by a multi-disciplinary panel of specialists focus on implementation of novel treatments and technologies for which level 1 evidence is lacking.

Hutchmed (China) is evaluating supply-chain options for a blood-cancer drug recently ... The approval is for ...